Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Pharmaceutical

Aldeyra Therapeutics

Todd C. Brady

Bruce Greenberg

David J. Clark

Stephen G. Machatha

David B. McMullin

David Noskowitz

Lise L. Kjems

Christopher Pearson

The executive team at Aldeyra Therapeutics has a wealth of experience in the pharmaceutical industry. The team members have worked for companies such as Domain Associates and have a variety of educational backgrounds, including degrees from Duke University's Graduate School of Pathology. This experience and knowledge is what drives the company to success.

CEO and Executive Team

Leadership Team

Board of Directors

CEO and Executive Team

About

Team members

Other teams at Aldeyra Therapeutics

Leadership Team

Board of Directors